M. Alexandre

Also affiliated with Inserm, Université Paris-Est Créteil, Nord University, Université Sorbonne Paris Nord, Assistance Publique – Hôpitaux de Paris, Bordeaux Population Health, Institut de Recherche en Cancérologie de Montpellier

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Omalizumab in the treatment of bullous pemphigoid resistant to first-line therapy: a French national multicentre retrospective study of 100 patients”.

Omalizumab in the treatment of bullous pemphigoid resistant to first-line therapy: a French national multicentre retrospective study of 100 patients

British Journal of Dermatology(2023)10.1093/bjd/ljad369

N/A

0DataRank · unranked

44 citations

F. Lombart, G. Chaby, A. Dadban, S. Debarbieux, M. Viguier +28 more

Evaluation of waning of IgG antibody responses after rVSVΔG-ZEBOV-GP and Ad26.ZEBOV, MVA-BN-Filo Ebola virus disease vaccines: a modelling study from the PREVAC randomized trial

Leiden Repository (Leiden University)(2024)10.1080/22221751.2024.2432353#abstract

N/A

0DataRank · unranked

0 citations

M. Alexandre, M. Prague, AH Beavogui, S. Doumbia, Kieh, M., +17 more